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Translocation of cyclin B1 to the nucleus at prophase requires a
phosphorylation-dependent nuclear import signal
Anja Hagting, Mark Jackman, Karen Simpson and Jonathon Pines
Background: At M phase, cyclin B1 is phosphorylated in the cytoplasmic
retention sequence (CRS), which is required for nuclear export. During
interphase, cyclin B1 shuttles between the nucleus and the cytoplasm because
constitutive nuclear import is counteracted by rapid nuclear export. In M phase,
cyclin B moves rapidly into the nucleus coincident with its phosphorylation, an
overall movement that might be caused simply by a decrease in its nuclear
export. However, the questions of whether CRS phosphorylation is required for
cyclin B1 translocation in mitosis and whether a reduction in nuclear export is
sufficient to explain its rapid relocalisation have not been addressed.
Results: We have used two forms of green fluorescent protein to analyse
simultaneously the translocation of wild-type cyclin B1 and a phosphorylation
mutant of cyclin B1 in mitosis, and correlated this with an in vitro nuclear import
assay. We show that cyclin B1 rapidly translocates into the nucleus
approximately 10 minutes before breakdown of the nuclear envelope, and that
this movement requires the CRS phosphorylation sites. A cyclin B1 mutant that
cannot be phosphorylated enters the nucleus after the wild-type protein.
Phosphorylation of the CRS creates a nuclear import signal that enhances cyclin
B1 import in vitro and in vivo, in a manner distinct from the previously described
import of cyclin B1 mediated by importin β.
Conclusions: We show that phosphorylation of human cyclin B1 is required
for its rapid translocation to the nucleus towards the end of prophase.
Phosphorylation enhances cyclin B1 nuclear import by creating a nuclear import
signal. The phosphorylation of the CRS is therefore a critical step in the control
of mitosis.
Background
One of the most important protein kinases in the regula-
tion of mitosis is the complex of cyclin B with its partner
catalytic subunit, cyclin-dependent kinase 1 (Cdk1). At
each mitosis and meiosis in animal cells, cyclin B1 is phos-
phorylated on Ser–Pro sites [1–3] that are evolutionarily
conserved, but the consequence of this is unclear. A non-
phosphorylatable mutant of cyclin B1 is still able to bind
and activate its partner Cdk1, and is degraded at the
correct time in mitosis [1,2]. Experiments assaying the
ability of Xenopus cyclin B1 to promote meiotic maturation
have demonstrated a requirement for the mitosis-specific
phosphorylation sites in the amino terminus of the protein
[2,4]. More specifically, these sites are in the cytoplasmic
retention sequence (CRS), which is necessary and suffi-
cient to direct cyclin B1 into the cytoplasm [5]. 
One change in cyclin B1 behaviour that correlates with its
phosphorylation when cells enter meiosis or mitosis is that
it moves from the cytoplasm into the nucleus [6–8]. This
movement is probably connected with the putative role of
the cyclin B–Cdk1 complex as the nuclear lamin kinase
that causes nuclear envelope disassembly at the end of
prophase. Cyclin B1–Cdk1 will phosphorylate the nuclear
lamins, both in vitro and in vivo [9–11], on residues on
either side of the coiled-coil region that are required for
disassembly [9,12]. A mutant form of cyclin B1 in which
the phosphorylation sites in the CRS are mutated to non-
phosphorylatable alanines is unable to cause Xenopus
oocytes to enter meiosis [2,4]. This mutant did not accu-
mulate in the nuclei of maturing oocytes, but it could be
made to cause meiotic maturation by targeting it to the
nucleus with a SV40 T-antigen nuclear localisation signal
(NLS) [4]. Thus, the ability to enter the nucleus is
required for cyclin B1–Cdk1 to promote entry into
meiosis, and probably to promote mitosis in somatic cells. 
Recently, the ability of the CRS to direct cyclin B1 to the
cytoplasm was shown to be because it has a stretch of
hydrophobic residues that acts as a nuclear export signal
(NES) [13–15]. Cyclin B1 export is sensitive to the drug
leptomycin B, and therefore uses an exportin 1/Crm1-
dependent pathway, and indeed the CRS of Xenopus
cyclin B1 has been shown to associate with exportin 1 in
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Xenopus extracts [15]. The physiological role of cyclin B1
nuclear export, however, is disputed. There are some data
to suggest that an export-defective form of cyclin B1 com-
promises the DNA-damage checkpoint in G2 phase
[14,16], whereas other studies suggest that nuclear cyclin
B1 can have a protective effect [13,17].
When the NES of cyclin B1 is inactivated, or when cells
are treated with leptomycin B to inhibit nuclear export,
cyclin B1–Cdk1 accumulates in the nucleus [13–15]. This
shows that cyclin B1–Cdk1, or an associated protein, has
an NLS and that throughout S and G2 phases the complex
must be continuously shuttling between the nucleus and
the cytoplasm. Although neither cyclin B nor Cdk1 have a
recognisable SV40-like or bipartite NLS [18], a deletion
mutant of Xenopus cyclin B1 that lacked its amino termi-
nus, including the CRS, has been shown to bind directly
to importin β [19]. 
The identification of an NES in cyclin B1 raises the possi-
bility that its translocation into the nucleus at mitosis and
meiosis could simply be a consequence of the inhibition of
its nuclear export. Indeed, Xenopus cyclin B1 binds much
less exportin 1 in meiotic oocyte extracts [15]. A mutant
form of human cyclin B1 with a defective NES takes
several hours to accumulate in the nucleus [13], however,
whereas the translocation of wild-type cyclin B1 in
prophase takes approximately 10 minutes. This suggests
that translocation might also require enhanced nuclear
import, perhaps via the importin β pathway. We have used
real-time imaging of cyclin B1–green fluorescent protein
(GFP) fusion proteins as cells enter mitosis to address the
mechanism of translocation. We show that translocation is
not simply a consequence of inhibiting export; it also
involves the generation of a NLS in the amino terminus
through phosphorylation of the CRS. Moreover, this
appears to be distinct from the importin β-dependent
import signal previously described for cyclin B1.
Results
All five serine residues in the CRS can be phosphorylated
in mitotic cell extracts
The CRS of human cyclin B1 contains five serine residues
that are in analogous positions to the mitosis-specific
phosphorylation sites mapped in Xenopus and sea urchin
B-type cyclins [2,20] (Figure 1a). To study the importance
of cyclin B1 phosphorylation we generated point mutants
in which we changed the serine residues in the CRS to
either threonine (T) or to non-phosphorylatable alanine
(A) residues, expressed them and the wild-type cyclin B1
as glutathione-S-transferase (GST) fusion proteins in bac-
teria, purified them by affinity chromatography on glu-
tathione–Sepharose, and mixed them with cell lysates
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Figure 1
Cyclin B1 is phosphorylated on conserved phosphorylation sites in the
CRS. (a) The CRS regions of human (Hs), Xenopus laevis (X), and the
sea urchin Arbacia punctulata (Ap) were aligned by eye. Identical
residues are connected with a vertical line and conserved substitutions
are marked with an asterisk. The phosphorylation sites in human cyclin
B1 are in bold and marked with bullet points. (b) Wild-type cyclin B1,
(WT) and a quintuple alanine mutant of the five phosphorylation sites
(5×A), were purified as GST-tagged proteins and bound to glutathione-
coated Sepharose beads. Cyclin-B1-coated beads were used as an
affinity matrix to isolate associated kinase activity from G1/S- and
M-phase HeLa cell extracts (each prepared from ~1.5 × 106 cells).
Cyclin B1 phosphorylation was assayed in vitro in the presence of
[γ32-P]ATP. Cyclin B1 was cleaved from the GST domain using
thrombin, and analysed by SDS–PAGE and autoradiography (top
panel). The level of phosphorylation was quantified after analysis on a
phosphorimager using Mac Bas software (Fuji; bottom panel). (c) Wild-
type cyclin B1 and serine-to-threonine point mutants (S116T, S126T,
S128T, S133T and S147T) were purified as GST-tagged proteins and
used to isolate associated cyclin B1 kinase activity from G2/M-phase
HeLa cell extracts (prepared from ~7 × 106 cells). Cyclin B1
phosphorylation was assayed in vitro in the presence of [γ33-P]ATP.
Cyclin B1 was cleaved from the GST domain using thrombin, and
phosphoamino-acid analyses carried out. Pi, inorganic phosphate; Ori,
origin; S, Serine; T, Threonine. No phosphotyrosine was detectable.
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from synchronised HeLa cells. The mutants were func-
tional in that they were able to bind Cdk1 and activate it
to the same extent as wild type (data not shown). We
found wild-type cyclin B1 was much more heavily phos-
phorylated by an associated kinase activity in mitotic cell
extracts than in interphase extracts (Figure 1b), and, as
previously observed for Xenopus cyclin B1 [2], when we
mutated all five serines to alanines (mutant 5×A) we com-
pletely eliminated phosphorylation (Figure 1b). By phos-
phoamino-acid analysis, human cyclin B1 was shown to be
phosphorylated only on serine residues; therefore we
made point mutations to change individual serines into
threonine residues, and analysed their phosphorylation
state by phosphoamino-acid analysis. We found that S126
was the major site of phosphorylation in late G2/M phase
extracts (Figure 1c). About 50% of the phosphate was
incorporated into this site, and the other four sites were
phosphorylated to an approximately equal extent.
Recently, Meijer and colleagues have shown that in
starfish the phosphorylation of cyclin B1 in meiosis is pri-
marily because of autophosphorylation [20]. We found
that all five sites in human cyclin B1 could also be
autophosphorylated in vitro (data not shown), but we were
unable to exclude the possibility that there might be
another kinase involved in their phosphorylation in vivo.
Cyclin B1 translocation assayed using fusion proteins
containing GFP or yellow fluorescent protein (YFP) that
can be distinguished in vivo
To assay the effects of altering the CRS phosphorylation
sites on cyclin B1 translocation at mitosis, we set up an assay
to distinguish the behaviour of the mutant proteins from the
wild type in real time. We constructed fusion proteins
between wild-type human cyclin B1 and the F64L/S65T
version of GFP (MmGFP, excitation maximum 490 nm,
emission maximum 512 nm), and fused the phosphoryla-
tion-site mutants of cyclin B1 to YFP [21] (excitation
maximum 515 nm, emission maximum 525 nm), and vice
versa. We designed a filter set to distinguish between these
two mutants (Figure 2 and see Materials and methods
section) and introduced the cDNAs by microinjection into
G2-phase cells that had been synchronised by a thymidine
and aphidicolin regime. The fusion proteins were visible
approximately 3 hours after cDNA microinjection, and were
monitored by time-lapse fluorescence microscopy. 
We compared the translocation of the cyclin B1 fusion pro-
teins with respect to the time of nuclear envelope break-
down as assayed by both differential interference contrast
(DIC) imaging and the time at which TRITC-labelled
dextran (molecular weight 70,000 Da) entered the nuclei.
We found that the mutant form of cyclin B1 in which we
altered all the CRS serine residues to glutamic acids to
mimic phosphorylation (mutant 5×E) partially accumulated
in the nucleus throughout interphase (Figure 3a). In con-
trast, wild-type cyclin B1 was predominantly cytoplasmic
throughout G2 phase until it very rapidly translocated into
the nucleus over a period of about 6 minutes towards the
end of prophase. Translocation began more than 6 minutes
before nuclear envelope breakdown as visualised by DIC
microscopy (Figure 3b, bottom row), or by the movement
of Texas-Red-labelled dextran into the nucleus (Figure 3b,
middle row). The cyclin B1 phosphorylation mutant in
which all the serine residues were altered to alanine
residues (5×A), however, translocated significantly later
than the wild-type protein, ~3 minutes before Texas
Red–dextran entered the nucleus (data not shown, but see
below). This suggested that the 5×A mutant might enter
the nucleus just before the nuclear envelope began to dis-
assemble, but we noticed that Texas-Red–dextran did not
diffuse rapidly within the cell and therefore might not
reflect the exact time at which the nuclear envelope
became porous. Thus, we made use of a constitutively
cytoplasmic protein, a GST–GFP fusion protein linked to
the NES of RanBP1 (GG–NES, gift of I. Macara, and see
[22]). This protein does not have a recognisable nuclear
import signal and so cannot enter the nucleus even when
its nuclear export is inhibited by leptomycin B (Figure 4a).
We found that the 5×A mutant of cyclin B1 and the
GG–NES construct entered the nucleus at the same time
in mitosis, suggesting that the 5×A mutant of cyclin B1
could only enter the nucleus when the nuclear envelope
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Figure 2
Green fluorescent protein and yellow fluorescent protein can be
distinguished using the JP3 GFP/YFP filterset. Expression constructs
of the cDNAs encoding cyclin B1–GFP or cyclin B1–YFP, driven by
the cytomegalovirus (CMV) promoter, were injected into the nuclei of
G2-phase HeLa cells. Fluorescence images were taken 4 h after
injection with the GFP/YFP filter set, using 250 msec (GFP) and
50 msec (YFP) exposures and a gain of 3 units on the intensifier.
(a,b) Cyclin B1–GFP fluorescence images were taken with the GFP
filterset (a) or the YFP filterset (b). (c,d) Cyclin B1–YFP fluorescence
images were taken with the GFP filterset (c) or the YFP filterset (d).
Raw unprocessed image files are shown. In these files background
fluorescence is displayed as a uniform grey image (b,c).
(a) (b)
(c) (d)
Cyclin B1–GFP
Cyclin B1–YFP
GFP filterset YFP filterset
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began to break down (Figure 4b). To confirm this, we
coexpressed the cyclins with a mutant form of human lamin
A in which serine residues crucial to lamin disassembly had
been mutated to alanine residues [12] (gift of R. Heald).
We reasoned that because this mutant inhibits the disas-
sembly of the nuclear lamina it should increase the time
between translocation of wild-type cyclin B1 and the non-
specific entry of protein through the disassembling nuclear
lamina. In cells expressing the mutant form of lamin A, the
cyclin B1 5×A mutant entered the nuclei more than
6 minutes after the wild-type protein (Figure 4c). Thus it
appears that the CRS of cyclin B1 must be phosphorylated
to allow the protein to translocate into the nucleus.
Wild-type cyclin B1 and the 5×A mutant differ in their
nuclear import rates
Our results suggested that phosphorylation of the CRS in
cyclin B1 enhanced its ability to enter the nucleus at the
end of prophase. This could be through an effect on
nuclear import, or export, or both. To distinguish between
these possibilities, we injected wild-type and mutant
cyclin B1–GFP cDNA expression constructs into cells and
then treated the cells with leptomycin B (gift of
M. Yoshida), which blocks exportin-1-mediated nuclear
export [23,24] of cyclin B1 [13–15]. We found that the 5×E
mutant entered nuclei much faster than wild-type cyclin
B1 after leptomycin B treatment (Figure 5, compare a,c,d).
In contrast, the 5×A mutant of cyclin B1 accumulated in
nuclei at a much slower rate (Figure 5b,d). This suggested
that the phosphorylation of the CRS was affecting the
ability of cyclin B1 to enter nuclei independently of an
effect on its rate of export. 
Phosphorylation-dependent nuclear import has been
described for a number of proteins. In some cases the
protein was released from a cytoplasmic anchor, whereas
in other cases, phosphorylation created a nuclear import
signal or inhibited nuclear export. To determine the
mechanism by which cyclin B1 import was regulated by
phosphorylation we used the well characterised in vitro
nuclear import system based on permeabilised HeLa cells
to which purified nuclear import components can be
added to reconstitute nuclear transport [25,26]. This
system has also been used to show that an amino-terminal
deletion mutant of Xenopus cyclin B1 lacking its CRS was
imported into nuclei by binding directly to importin β
[19]. We used the full length cyclin–GFP chimaeras as
substrates in the nuclear import assay. 
Wild-type cyclin B1–GFP was not significantly imported
into nuclei in the presence of interphase cell extract, but its
import was greatly enhanced in the presence of mitotic
extract (Figure 6a). In contrast, the 5×A mutant was not
imported in the presence of either interphase or mitotic
extract (Figure 6a). These results suggested that cyclin B1
nuclear import was phosphorylation dependent in the
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Figure 3
Cyclin B1 5×E–GFP
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The phosphorylation state of the CRS alters nuclear import of cyclin
B1. (a) Cyclin B1 5×E, in which all five serine residues in the CRS
have been changed to glutamic acid, partially accumulates in the
nucleus throughout interphase. cDNA constructs expressing cyclin B1
5×E–GFP (top) or cyclin B1–GFP (bottom) from the CMV promoter
were injected into the nuclei of early S-phase HeLa cells. Fluorescence
images were taken 4.5 h after injection of cDNA. (b) Translocation of
wild-type cyclin B1 is completed before nuclear envelope breakdown.
A cDNA construct expressing cyclin B1–GFP from the CMV promoter
was injected into the nuclei of late G2-phase HeLa cells 3 h before the
injection of 1 mg/ml Texas Red-conjugated dextran into the cytoplasm.
Fluorescence and differential interference contrast (DIC) images were
captured at the indicated times after injection of conjugated dextran.
Top row, wild-type cyclin B1–GFP; middle row, Texas Red–dextran;
bottom row: DIC images. Representative results of at least three
different experiments are shown.
in vitro system. To determine whether this effect could be
ascribed to proteins in the interphase cell extracts that
were masking or anchoring cyclin B1, we assayed cyclin B1
import in the presence of nuclei, ATP and purified nuclear
import factors only. Under these conditions, the 5×A
mutant was not imported into nuclei, wild-type cyclin B1
was imported to a small extent, and the 5×E mutant was
efficiently imported (Figure 6b). We were able to exclude
the possibility that this effect was simply due to a reduc-
tion in the export rate of the cyclin because a mutant form
of cyclin B1 with a defective NES (F146A) [13] was not
imported into nuclei any more efficiently than the wild-
type protein (Figure 6b). Thus, it appeared that altering
the phosphorylation state of the CRS had a direct effect on
the ability of cyclin B1 to be imported into nuclei. 
The amino terminus of cyclin B1 has a phosphorylation-
dependent nuclear import signal
Given that phosphorylation of the CRS appeared to affect
the nuclear import of cyclin B1 in the probable absence of
cytoplasmic anchors or masking proteins, we considered
the possibility that phosphorylation might have created a
nuclear import signal on the amino terminus of cyclin B1.
To test this we fused GFP to the amino terminus of
cyclin B1, either to the wild-type protein or to the 5×A or
5×E mutant, and assayed nuclear import in the in vitro
system in the presence or absence of purified transport
factors. The 5×E amino terminus was able to import GFP
into the nucleus, but the 5×A mutant was not (Figure 7a).
These results were also seen when we microinjected
these constructs into tissue culture cells (data not shown).
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Figure 4
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Cyclin B1 5×A–YFP Merge
0 min 1.5 h
Translocation of cyclin B1 requires a phosphorylated CRS.
(a) Leptomycin B does not cause nuclear accumulation of
GST–GFP–NES. The GST–GFP–NES fusion protein was injected into
the cytoplasm of G2-phase HeLa cells. After 3 h, 20 nM leptomycin B
was added to the cells, after which fluorescence images were taken at
the indicated time points. Exposure is 250 msec. (b) Cyclin B1 5×A
enters the nucleus when the nuclear envelope begins to break down.
An expression construct of the cDNA (0.01 mg/ml) encoding cyclin B1
5×A–YFP, driven by the CMV promoter, was injected into the nuclei of
G2-phase HeLa cells. Three hours later, GST–GFP–NES (GG–NES)
was injected into the cytoplasm of cells expressing cyclin B1
5×A–YFP, and fluorescence and DIC images were taken every 2 min,
with exposure times of 500 msec and 200 msec for GFP and YFP,
respectively. Top row, cyclin B1 5×A–YFP; middle row, GG–NES;
bottom row, DIC images. The cell indicated by an arrow enters mitosis.
Representative results of at least three different experiments are shown.
(c) Wild-type cyclin B1 enters the nucleus before a non-
phosphorylatable mutant cyclin. The cDNAs expressing cyclin
B1–GFP, cyclin B1 5×A–YFP (0.02 mg/ml) and a mutant nuclear lamin
A (S22A, S392A), all driven by the CMV promoter, were co-injected
into the nuclei of late G2-phase HeLa cells. Fluorescence images were
taken every 3 min, using a gain of 3 units on the intensifier, a 0.1
neutral density filter, and exposures of 500 msec and 50 msec for GFP
and YFP, respectively. Left column, wild-type cyclin B1 (green); middle
column, 5×A mutant (red); right column: merged image. Representative
results of at least five different experiments are shown. 
Furthermore, importin β was unable to stimulate the
import of either the 5xE (Figure 7a) or the wild-type
amino terminus of cyclin B1 linked to GFP under condi-
tions where it did stimulate the import of a SV40 NLS
substrate in vitro (Figure 7a), suggesting that this phos-
phorylation-dependent import used a different pathway
from that described for cyclin B1 without its amino termi-
nus. Like the full-length cyclin B1, the wild-type cyclin
B1 amino terminus could import GFP into the nucleus in
the presence of mitotic cell extract, but not in the pres-
ence of interphase extract (Figure 7b). Thus, it appears
that phosphorylation of the cyclin B1 CRS in mitosis
creates a nuclear import signal on its amino terminus that
contributes to the rapid translocation of cyclin B1 to the
nucleus at the end of prophase.
Discussion
We have shown that the rapid translocation of cyclin B1
into the nucleus at mitosis is regulated by phosphorylation
of the CRS. By imaging cyclin B1–GFP fusion proteins in
live cells we find that cyclin B1 normally translocates into
the nucleus within ~10 minutes. This rapid translocation
begins late in prophase, after the nucleoli have disap-
peared and when chromosome condensation has largely
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Figure 5
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Cyclin B1 5×E enters the nucleus much faster than wild-type or the
5×A mutant does. The cDNAs expressing (a) cyclin B1–GFP,
(b) cyclin B1 5×A–GFP or (c) cyclin B1 5×E–GFP were injected into
nuclei of late G2-phase HeLa cells. After 3 h, 20 nM leptomycin B was
added to the cells. Fluorescence images were taken at the indicated
times after the addition of leptomycin B (250 msec exposures). (d) The
percentage of cells with nuclear cyclin B1 (that is, cells in which the
amount of cyclin B1 in the nucleus was greater than that in the
cytoplasm) was calculated at the indicated time points. Representative
results of at least three different experiments are shown.
Figure 6
The phosphorylation state of the CRS alters cyclin B1 import.
(a) Mitotic cell extract stimulates nuclear import of cyclin B1–GFP.
Permeabilised HeLa cells were incubated in 2 mg/ml S-phase or
1.5 mg/ml M-phase HeLa cell extract and an energy-regenerating
mixture with either cyclin B1–GFP or cyclin B1 5×A–GFP. After 10 min
incubation at 37°C, cells were fixed and nuclear uptake was visualised
by confocal fluorescence microscopy. (b) Mutations in the CRS create
a constitutive nuclear localisation signal (NLS). Permeabilised HeLa
cells were incubated in nuclear import buffer containing 0.2 µM
importin β, 0.5 µM Ran-GDP, 0.5 µM NTF2 and an energy-regenerating
mixture with 3 µM of either cyclin B1 5×A–GFP, cyclin B1–GFP, cyclin
B1 5×E–GFP or a nuclear-export-defective cyclin B1 mutant
(F146A)–GFP. After 10 min incubation at 22°C, cells were fixed and
nuclear uptake was assayed by confocal fluorescence microscopy. 
S phase M phase
5×A–GFP
Cyclin B1–GFP
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finished. Thus it is possible that the initial nuclear events
of prophase are not caused by cyclin B1–Cdk1, but by
another protein kinase that is active at the beginning of
mitosis. Indeed, we have evidence to suggest that they
might depend on cyclin A–CDK complexes (N. Furuno
and J.P., unpublished observations). Very soon after cyclin
B–Cdk1 has translocated into the nucleus, the nuclear
envelope breaks down, and this correlates with the postu-
lated role of cyclin B–Cdk1 as the lamin kinase. Further-
more, in cells that are expressing a non-phosphorylatable
lamin, cyclin B1–Cdk1 translocates into the nucleus and
then markedly associates with the nuclear periphery,
which might be indicative of a stabilised enzyme–sub-
strate interaction (data not shown). 
We have been able to visualise two different GFP fusion
proteins with a custom filter set that can distinguish the
F64L/S65T version of GFP from YFP. This filter set
might prove useful to other researchers who are attempting
co-localisation studies in living cells, although a sensitive
camera is required to acquire the GFP image. With this
filter set we show that a mutant of cyclin B1 in which we
altered phosphorylation sites in the CRS to alanine
residues (5×A) only enters the nucleus once the nuclear
envelope begins to break down. Conversely, a mutant in
which we altered the sites to glutamic acid residues (5×E),
to mimic phosphorylation, gradually accumulates in the
nucleus during interphase, but at a very much slower rate
than cyclin B1 at mitosis. These differences are also
observed in the presence of leptomycin B, which inhibits
exportin 1/Crm1-dependent export — including the export
of cyclin B1 — suggesting that the mutations are affecting
the rate of nuclear import. 
We confirmed these results using a purified in vitro nuclear
import system. We found that the full-length protein or the
amino terminus of cyclin B1 could import GFP into nuclei
when the CRS contained the 5×E mutations, but not with
the 5×A mutations. Wild-type cyclin B1 or its amino termi-
nus could only import GFP when it was incubated in the
presence of mitotic extract. In the in vitro nuclear import
system there was very little nuclear export (M.J., unpub-
lished observations), and there was no apparent difference
between the wild-type cyclin B1 and a mutant with a
defective NES. This further supports our interpretation
that these effects were due to changes in the rate of
nuclear import and not of export. Furthermore, the oppo-
site effects of the 5×E and 5×A mutants were observed
with nuclei, Ran and an energy source only, making it
unlikely that the 5×A prevents nuclear import by binding
to a cytoplasmic anchor. Thus a nuclear import signal
seemed to be created on the amino terminus of cyclin B1
through phosphorylation of the CRS. In interphase, the
(5×E) mutation shifted the equilibrium between nuclear
and cytoplasmic cyclin B1 towards more cyclin B1 in the
nucleus. This suggested that phosphorylation of the cyclin
B1 CRS enhanced the import of cyclin B1 in interphase,
but that the effect was counteracted by its nuclear export. 
A phosphorylation-dependent nuclear localisation signal
has recently been described for Dorsal protein [27], the
Rel protein homologue in Drosophila. There is no apparent
homology between Dorsal and cyclin B1 in the phosphory-
lation sites — a protein kinase A site in Dorsal — or in the
regions immediately adjacent. Conversely, a cyclin–CDK
phosphorylation-dependent nuclear export signal has been
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Figure 7
The amino terminus of cyclin B1 acts as a phosphorylation-dependent
NLS. (a) Nuclear import of the CRS is independent of importin β.
Permeabilised HeLa cells were incubated in nuclear import buffer
containing 0.5 µM Ran-GDP, 0.5 µM NTF2 and an energy-
regenerating mixture with either 3 µM cyclin B1(1–161) 5×A–GFP,
cyclin B1(1–161) 5×E–GFP or SV40 NLS–BSA–TRITC and 0.4 µM
importin α. In the right-hand panels, import substrates were pre-
incubated with 0.2 µM importin β before addition to the import assay.
After 10 min incubation at 22°C, cells were fixed and nuclear uptake
was assayed by confocal fluorescence microscopy. (b) Mitotic cell
extract can stimulate nuclear import of the CRS. Permeabilised HeLa
cells were incubated in interphase (S-phase) or M-phase HeLa cell
extract and an energy-regenerating mixture with 3 µM cyclin
B1(1–161)–GFP. After 10 min incubation at 37°C cells were fixed and
nuclear uptake was assayed by confocal fluorescence microscopy. 
(a)
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identified for the Pho4 transcription factor in budding
yeast [28,29]. Our studies have not conclusively identified
the kinase responsible for phosphorylation of the CRS.
Recombinant cyclin B1–Cdk1 purified from bacteria is
able to phosphorylate the sites in the CRS — primarily on
S126 — although we were unable to assay any difference
in the translocation of S126A compared with the wild-type
protein. Meijer and colleagues have shown that autophos-
phorylation is the principal pathway for cyclin B1 phos-
phorylation in maturing starfish oocytes [20]. Thus it is
possible that when cyclin B1–Cdk1 is activated at mitosis
the complex will autophosphorylate and consequently
translocate to the nucleus. However, this does not exclude
the possibility that an initial ‘trigger’ kinase is also
involved in the same way that polo-like kinase1 (Plk1) is
thought to activate Cdc25C before its phosphorylation by
cyclin B–Cdk1 as part of an autoamplification loop
[30,31]. Indeed, the NIMA kinase is required for nuclear
localisation of cyclin B1 in the fungus Aspergillus nidulans
[32] by a mechanism that may require the SONA nuclear
transport protein. 
Translocation of cyclin B1 to the nucleus at prophase is
also likely to involve a reduction in its rate of nuclear
export. Exportin 1/Crm1 binds less efficiently to Xenopus
cyclin B1 in mitotic extracts, and a mutant cyclin B1 with
glutamic acids replacing the serines in the CRS was
exported much less efficiently from Xenopus oocytes [15].
We also found that the 5×A mutant of cyclin B1 was
exported more rapidly from nuclei than the wild-type
protein or the 5×E mutant (data not shown). Our data
suggest that the primary change in the import behaviour
of phosphorylated cyclin B1 at mitosis is the creation of a
nuclear import signal in the amino terminus. 
A mutant of Xenopus cyclin B1 lacking the amino terminus,
including the CRS, has been shown to bind directly to
importin β in interphase Xenopus extracts and be imported,
although slowly, into nuclei [19]. We found that importin β
had either no effect on, or slightly stimulated, the import of
full-length cyclin B1–GFP in vitro. Cyclin B1 import in
interphase might, therefore, be dependent on importin β.
We do not believe that the phosphorylation-dependent
NLS created on the CRS is recognised by importin β,
however, because importin β was unable to stimulate the
import of either the 5×E (Figure 7) or the wild-type amino
terminus linked to GFP (data not shown). Similarly, neither
importin α nor transportin were able to stimulate import,
and import of the 5×E mutant was not markedly enhanced
by the addition of cell extract (data not shown). The import
receptor or carrier appears, therefore, to be associated with
the nuclei or the permeabilised cells in the in vitro system. 
Conclusions
The translocation of cyclin B1 to the nucleus begins at the
end of prophase, after many of the nuclear events of
mitosis are already underway or completed, including
chromosome condensation and disassembly of the nucle-
oli. The rapid translocation of cyclin B1 is consequent on
an increase in its rate of import as well as a probable
decrease in its rate of export. The increase in nuclear
import rate depends on phosphorylation of the CRS, and
this creates a nuclear import signal in the amino terminus
of cyclin B1 that can target an exogenous protein to the
nucleus. The phosphorylation of the CRS is therefore key
to the localisation of cyclin B1 at the beginning of mitosis.
Materials and methods
Cell culture and synchronization
HeLa cells were cultured on plates in DMEM supplemented with 10%
calf serum at 37°C/10% CO2. Cells were synchronized using a thymi-
dine and aphidicolin regime as previously described [33]. For M-phase
extracts, cells were synchronised by release from a double thymidine
block and arrested in mitosis with nocodazole as described [33].
Construction of point mutants and chimaeras
Fusion proteins and point mutations were constructed by PCR using
VENT polymerase (Biolabs), cloned into bacterial expression vectors,
and sequenced on an automatic sequencer. pCMX–cyclin
B1–MmGFP and pRSETB–cyclin B1(1–161)–MmGFP have been
described previously [13]. pCMX–cyclin B1–MmGFP or pCMX–cyclin
B1 was used as a template to change serine residues 116, 126, 128,
133 and 147 into alanine, glutamic acid or threonine residues using the
overlap extension technique [34]. The cDNAs for the GST fusion pro-
teins were cloned into pGEX-2T (Pharmacia) using a seven amino acid
(SPGILDS) linker between GST and the start codon of cyclin B1. The
stop codon of cyclin B1 was mutated to a XbaI site to link it to YFP
using pEYFP (Clontech). The resulting plasmid was used for sub-
cloning cyclin B1–YFP into pCMX. All other constructs described are
subclones from these constructs. All sequences of primers used in this
study are available on request.
Protein expression and purification
Full-length GST–cyclin B1, GST–cyclin–GFP and GG–NES proteins
were expressed in E. coli C41 [35]. E. coli cells were grown at 37°C to
OD600 of ~0.5 and then induced for 6–8 h with 0.1 mM isopropylthio-
galactoside (IPTG) at 20–25°C. Cells expressing the GST proteins
were lysed by lysozyme and sonication. The proteins were purified
using glutathione–Sepharose 4B beads (Pharmacia). Cyclin B1–GFP
was cleaved from GST with thrombin (Sigma) according to the manu-
facturer’s instructions. Fusion proteins between the amino terminus of
cyclin B1 and MmGFP were expressed and purified as described [13].
For microinjections, proteins were concentrated in a Vivaspin 50000
MW cut-off microconcentrator (Vivascience), diluted ~300 times in
10 mM phosphate buffer pH 7.2 supplemented with 100 mM KCl, and
concentrated again. Protein concentrations were assayed using
Coomassie Plus Protein Assay Reagent (Pierce).
Preparation of HeLa cell extracts
HeLa cells were washed twice with ice-cold PBS. For M-phase cells,
the medium was also collected and any detached cells washed by cen-
trifugation (180 × g for 5 min at 4°C). Cells were detached from the
dish using a cell scraper, and transferred to a 15 ml centrifuge tube.
Cells were centrifuged at 180 × g for 5 min at 4°C. The cell pellet was
resuspended in an equal volume of hypotonic lysis buffer (25 mM NaCl,
20 mM Hepes-KOH pH 7.4, 1 mM EDTA, 1 mM dithiothreitol (DTT),
10 µg/ml cytochalasin B, 1 mM phenylmethanesulfonyl fluoride
(PMSF), protease inhibitor cocktail tablet (1 per 10 ml; Boehringer
Mannheim), 1 mM Na3VO4, 5 mM NaF, 1 µM microcystin LR) and incu-
bated on ice for 20 min before dounce homogenisation (~20 strokes).
During homogenisation, the salt concentration was increased to
0.15 M NaCl. The cell extract was incubated at 4°C for 30 min on a
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rotating wheel, subsequently clarified by centrifugation at 16,000 × g
for 5 min at 4°C, and kept on ice. 
Isolation of proteins using a GST–cyclin B1 affinity matrix and
in vitro kinase assays
HeLa cell extracts were first incubated with purified GST bound to glu-
tathione-coated Sepharose beads (~0.25 mg/ml) to remove non-specifi-
cally binding proteins. GST-coated beads were pre-washed with bead
buffer (150 mM NaCl, 20 mM Hepes-KOH pH 7.4, 1 mM EDTA, 1 mM
DTT, 1 mM PMSF, protease inhibitor cocktail tablet (1 per 10 ml), 1 mM
Na3VO4, 5 mM NaF) and incubated with extract (40 µl of beads per ml of
extract) at 4°C for 30 min on a rotating wheel. The beads were pelleted
(150 × g for 2 min), and the supernatant transferred to a fresh tube. Puri-
fied GST–cyclin B1 bound to glutathione-coated Sepharose beads
(~0.25 mg/ml) was added to the supernatant (15 µl beads per ml extract)
and incubated at 4°C for 2 h on a rotating wheel. The beads were pel-
leted and washed 3 times with 700 µl bead buffer at 4°C for 15 min on a
rotating wheel. The beads were subsequently washed with 700 µl kinase
buffer (150 mM NaCl, 20 mM Hepes-KOH pH 7.4, 10 mM MgCl2, 1 mM
DTT, 1 mM Na3VO4, 5 mM NaF), and incubated with 10 µl of kinase reac-
tion mixture (9.4 µl of kinase buffer; 0.3 µl of 1 mM ATP; 3.0 µCi of
[γ-33P]ATP) at 30°C for 30 min. Cyclin B1 was subsequently cleaved
from the GST domain using thrombin. The samples were analysed by
SDS–PAGE and autoradiography. For phosphoamino-acid analysis, the
samples were transferred to Immobilon-P membrane after SDS–PAGE.
Phosphoamino-acid analysis
Cyclin B1 was excised from Immobilon-P membrane and two-dimen-
sional phosphoamino-acid analysis carried out according to [36].
Time-lapse fluorescence imaging
Cells were injected with cDNA (0.1 mg/ml unless indicated otherwise in
the figure legend) or proteins using an Eppendorf semi-automatic microin-
jector attached to a Leica DMIRBE microscope. Cells were incubated in
CO2-independent medium without phenol red (Gibco), and overlaid with
mineral oil for long time courses, and maintained at 37°C using a ∆T
0.15 mm dish (Bioptechs). Cells were imaged by time-lapse fluorescence
microscopy using custom filter sets (Chroma Technology), a PentaMax
camera (Princeton Instruments) and a Lambda 10-2 filter wheel (Sutter)
controlled by a PowerWave computer (PowerComputing) running IP Lab
Spectrum software (Scanalytics) as described [37]. To distinguish GFP
and YFP fluorescence, we used a PentaMax camera with a Gen IV inten-
sifier (Princeton Instruments) and a custom filterset JP3 (Ex: D460/20,
HQ523/20, Em: D500/22, HQ568/50, Chroma Technology). To check
for nuclear envelope breakdown, Texas-Red-conjugated dextran,
70,000 Da (Molecular Probes) was injected into the cytoplasm.
In vitro nuclear import assay
Nuclear import assays were carried out as described [38]. Import reac-
tions were started by adding digitonin-permeabilised HeLa cells syn-
chronised to mid-S-phase to the following reaction mixture: 20 mM
Hepes-KOH pH 7.5, 150 mM potassium acetate, 3 mM magnesium
acetate, 250 mM sucrose, an energy-regenerating mixture (1 mM ATP,
100 µM GTP, 10 mM creatine phosphate, 50 µg/ml creatine kinase),
0.5 µM RanGDP, 0.5 µM NTF2 and 5 mg/ml BSA, or synchronised
HeLa cell extract supplemented with energy-regenerating mixture.
Nuclear import substrates were used at 3 µM. Relative concentrations
of GFP-tagged substrates were also measured by comparing their fluo-
rescence using a Perkin Elmer Fluorimeter. Nuclei were incubated for
10 min at 22°C or 37°C, fixed with 4% paraformaldehyde and cen-
trifuged through a 30% sucrose cushion onto polylysine-coated cover-
slips. Nuclear import was assayed by laser scanning confocal
microscopy using a Bio-Rad 1024 confocal microscope, and the rela-
tive amounts of fluorescent substrate imported were measured using
the Laser Sharp program (Bio-Rad) and IPLab Spectrum (Scanalytics).
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